Resource requirements for reintroducing elective surgery in England during the COVID-19 pandemic: a modelling study

Introduction

The outbreak of novel coronavirus SARS-CoV-2 and the disease COVID-19, were first reported in December 2019 in Wuhan, China¹ and the World Health Organisation declared a global pandemic in March 2020. The healthcare response to the COVID-19 pandemic has required rapid changes to the provision of secondary healthcare services, including the creation of new hospitals.^{2, 3} Critical care capacity has increased substantially in high income countries, requiring re-deployment of staff and equipment from other departments.⁴ Surgical services represent a large portion of healthcare activity, accounting for 5 million hospital admissions to the United Kingdom (UK) National Health Service (NHS) every year.^{5, 6} In March, National Health Service (NHS) England issued guidance to postpone non-urgent surgery from 15^th April.⁷ Only very urgent and emergency surgical treatments continued, with the cancellation of almost all planned cancer and non-cancer surgery.^{8, 9} However, the number of surgical procedures cancelled during the pandemic response, and the excess of untreated surgical disease, remain unknown.^{2, 8}

As the NHS response to the pandemic develops, there is a planned reintroduction of elective surgery with a particular focus on cancer surgery.¹⁰ However, the risk of SARS-CoV-2 transmission within hospitals is a concern and further complicated by uncertain rates of asymptomatic infection in the general population (17% to 56%).^{11, 12} Asymptomatic infection rates may be as high as 24% among healthcare staff.^{13, 14} New procedures introduced to protect patients and staff from virus transmission have reduced capacity for surgery, as has a lack of appropriately trained staff requiring redeployment to other clinical areas.^{2, 4} NHS plans to prevent in-hospital infection include preoperative patient screening, establishing ‘clean’ hospitals, routine staff testing and/or universal personal protective equipment (PPE).^{8, 15} However, the optimum strategy, resource requirements and time-scale for reintroducing elective surgery remain uncertain.¹⁵ Critical care utilisation remained high for patients with COVID-19 in some areas after the peak passed.¹⁶ Capacity for surgical care remains limited in operating rooms, post-anaesthetic recovery units and critical care units whilst the incidence of serious postoperative complications amongst patients with COVID-19 is very high.^{4, 17} A clear understanding of the number and type of overdue surgical procedures is urgently needed to inform national healthcare policies for reintroducing surgical services.

Hospital Episode Statistics (HES) data over five years from 2014 to 2019 were used to estimate the number of surgical procedures postponed in the NHS in England due to COVID-19. Multiple scenarios for the reintroduction of routine surgical activity over nine months, starting in June 2020, were modelled. Estimates of the cumulative national deficit of surgical procedures and the resource implications for ‘catching up’ with postponed procedures, in terms of hospital beds, critical care beds, PPE for staff, preoperative screening of patients for COVID-19, and the associated financial cost are presented.

Methods

An unabridged description of the methods is provided in the appendix.

Results

Some 1073 OPCS codes for Class 1 – 4 surgical procedures, representing a total of 22 513 872 surgical admissions between 1^st April 2014 and 31^st March 2019 (Figure 1). The monthly median number of procedures was 382 768 (Interquartile range [IQR]: 22 890) (supplementary table 3). If growth in the number of surgical procedures had continued according to a pre-pandemic trajectory, 4 547 534 (95%CI: 3 318 195 to 6 250 771) would have been performed between 1^st March 2020 and 28^th February 2021 (supplementary table 4). Patients aged over 60 years accounted for 32.7% of class 1, 43.9% of class 2, 53.7% of class 3 and 45.6% of class 4 surgical activity (supplementary table 5).

Surgical procedure volume

Between 1^st March and 31^st May 2020, 749 247 (95%CI: 513 564 to 1 077 448) surgical procedures will have been cancelled in comparison with observed pre-pandemic levels of activity (supplementary table 6). The widespread reintroduction of class 2 surgical activity from 31^st May 2020, was modelled for four scenarios of incrementally increasing activity (20% - 80%) that would reach pre-pandemic levels by 31^st August 2020 (supplementary table 7). Even if class 2 - 4 surgical procedures are reintroduced in a stepwise fashion between 1^st June 2020 and 28^th February 2021 to reach the predicted pre-pandemic level of activity, the number of cancelled surgical procedures would be 2 328 193 (95% CI: 1 483 834 to 3 450 043) procedures (table 1, figures 2-3). In a post-hoc sensitivity analysis assuming all classes of surgery restarted on 1^st June and took six months to get to normal capacity, the number of cancelled surgical procedures was estimated to be 1 551 560 (95%CI: 1 041 537 to 2 269 486) (supplementary table 11).

• Download figure
• Open in new tab

• Download figure
• Open in new tab

• Download figure
• Open in new tab

Discussion

The principal finding of this study is that, without a substantial increase in capacity, accumulated delays in surgical care will lead to a backlog of more than two million overdue or cancelled surgical procedures in the NHS in England by 28^th February 2021. This is equivalent to 45% of the total number of surgical procedures performed in England each year before the COVID-19 pandemic, and is larger than the existing waiting list to start surgical treatment in March 2020, which already stood at over 1.8 million patients.³⁰ The cost of clearing this post-pandemic waiting list is in excess of €5 billion, or 4.2% of the total NHS England budget.³¹ Additional costs of delivering surgical services under strict infection control procedures exceed €500 million, and include personal protective equipment, preoperative screening and extra bed-days in hospital. No attempt was made to model the reduced operating theatre utilisation efficiency, suggesting the true excess cost may be far greater. Nor does this estimate account for additional costs of contracts with non-NHS providers, or the costs of postoperative complications among surgical patients with COVID-19.^{4, 17} In order to reduce the size of any future backlog of overdue surgery, elective surgical services would need to be reintroduced at the earliest opportunity and at the maximum capacity possible. Whether this can be achieved safely remains unclear.¹⁵

Postoperative mortality is much higher in patients with COVID-19 infection, compared to the expected pre-pandemic rate.¹⁷ An international cohort study of more than 1000 patients with COVID-19 found the incidence of postoperative mortality was more than one in four patients, compared to an expected mortality rate of 1 in 30 patients undergoing emergency surgery.¹⁷ This will inevitably lead to higher resource use, longer in-patient lengths of stay and greater financial costs. Furthermore, emerging data from the UK suggests that as many as one in twelve healthcare workers had asymptomatic infection during the first peak of the pandemic, and were at risk of transmitting the virus to other staff and patients.¹⁴ Consequently, many surgeons may choose to avoid surgery in patients with COVID-19 infection, to reduce the active reservoir inside the hospital and to mitigate the higher-risk of postoperative mortality. When surgery does go ahead, the benefits must be weighed against the potential harm of bringing vulnerable patients into contact with SARS-CoV-2 and the potential risks to staff members. It is likely that preoperative screening for the virus and PPE for healthcare workers will become universal. It is estimated that by February 2021, over 160 000 SARS-CoV-2 PCR tests will be required every week for preoperative screening alone. Permanent infrastructure for testing will need to be included in strategic plans for pathology services to support elective surgery. There are no national data regarding the use of protective equipment at individual institutions. However, many societies have exercised caution and have advocated for the deployment of full PPE for all high risk procedures and examinations, including all aerosol generating procedures.²⁴

There are no published data on the rate of cancellation of surgery within the NHS in England during the COVID-19 pandemic response, of which we are aware. However, the results of this analysis are consistent with data from an international survey, which reported that the majority of both urgent cancer and non-cancer surgery were postponed during the peak of the pandemic.⁹ This analysis provides early evidence that disruption to surgical care has been widespread and reintroduction of this care will have substantial resource requirements that will differ between healthcare settings. Delays to the re-introduction of surgical procedures may result in increased secondary morbidity and mortality, not directly attributable to COVID-19 infection, but due to increased volume of undiagnosed surgical disease and delays to curative therapy.² If delays in surgical care result in higher incidence of more advanced disease, it is likely that postoperative morbidity and mortality will also increase, as well as critical care bed utilisation and hospital length of stay. Strategies for undertaking safe surgery after the pandemic, during a prolonged pandemic response, or if COVID-19 becomes endemic, include reorganisation of referral pathways, restructuring of the surgical workforce, dedicated surgical critical care resources, isolated ‘cold’ hospitals and prioritisation of certain patient groups.² If second or subsequent peaks of COVID-19 occur, it is likely surgical services will again be curtailed, with further increases in the number of cancelled procedures. NHS leaders should make plans for the future continuity of surgical care.

This analysis has several strengths. Robust national data were analysed that describe the whole healthcare setting of a single country according to a prospectively published statistical analysis plan. Conservative estimates are purposely provided of estimates of procedure volume and associated resource requirements. Procedures are reported at the admission level, rather than the episode level, which will likely underestimate the volume of surgery. Assignment to urgency class based on mean wait time may lead to some inappropriate classification of individual procedures but was the only feasible option. Multiple sources were used to calculate postoperative critical care admission, which did not include preoperative admission, nor increased critical care utilisation for patients with COVID-19. Estimates of PPE only include usage in operating theatre, but not on postoperative wards or in clinics. Cost estimates do not take account of potential future reorganisation of care pathways, the use of ‘hot’ and ‘cold’ sites or use of private sector hospitals. This analysis also has limitations. A series of assumptions were made based on NHS England guidance, which were applied to a series of plausible scenarios regarding the continuation of surgical activity during the pandemic.^{7, 10} However, the reality of the volume, type and timing of continuation and reintroduction of surgery may differ from these models. The models implemented in this analysis are highly sensitive to the rate and timing of the resumption of surgical care, as evidenced by the much lower cumulative deficit in the sensitivity analysis. It will only be possible to test this in retrospect once actual numbers of procedures carried out are published. Our analysis does not account for lower throughput of surgery due to stricter infection control procedures or a potential second peak of COVID-19.³² Further research is urgently needed to address these issues. It is likely that the volume of emergency surgery that has continued during the pandemic is lower than pre-pandemic levels, perhaps due to patients avoiding hospital or clinicians using alternative management strategies.³³ The age distribution of the surgical population is skewed.⁶ However, due to limitations of the data source, age adjustment in the analysis was not possible. It is likely that, unfortunately, some patients waiting for surgery will have died while waiting to have their surgery. The numbers of these cases are unknown, and it was not possible to account for these in the analysis. It is likely that patients who have delayed care will have higher care needs and associated financial costs. There will also be higher human costs in terms of chronic symptoms and disability that it was not possible to account for in this analysis.² This analysis will be updated as new data become available.

In conclusion, accumulated delays in surgical care due to COVID-19 will lead to a backlog of more than two million overdue or cancelled surgical procedures in the NHS in England by 28^th February 2021. These delays in care are likely to be associated with increased mortality. The procedure cost of clearing this waiting list is more than €5.3 billion, with additional costs of at least €400 million for personal protective equipment and preoperative screening. Further research is needed to provide regular reports of NHS surgical activity across the United Kingdom, to support strategic planning of the re-introduction of elective surgery nationwide.

Contributions

AF, TD and TA were responsible for study design. RL, SH, TD, YW and AF were responsible for data collection. AF and TA were responsible for data analysis. AF, TD, RP and TA were responsible for data interpretation. TA wrote the first draft of the manuscript. All authors revised the manuscript for important intellectual content and approved the final version.

Declarations of interest

AJF reports a grant from the National Institute for Health Research (DRF-2018-11-ST2-062). TDD reports funding from the Welsh Clinical Academic Training (WCAT) Fellowship. IW reports active grants from the American Association of Plastic Surgeons and the European Association of Plastic Surgeons; is an editor for Frontiers of Surgery, associate editor for the Annals of Plastic Surgery, editorial board of BMC Medicine and numerous other editorial board roles. RP reports grants from NIHR, during the conduct of the study; grants and personal fees from Edwards Life Sciences, grants and non-financial support from Intersurgical UK, outside the submitted work; and has given lectures and/or performed consultancy work for Nestle Health Sciences, BBraun, Intersurgical, GlaxoSmithKline and Edwards Lifesciences, and holds editorial roles with the British Journal of Anaesthesia, the British Journal of Surgery and BMJ Quality and Safety. TA is a member of the associate editorial board of the British Journal of Anaesthesia. All other authors report no relationships or activities that could appear to have influenced the submitted work.

Data sharing

The data source is freely available online, the analysis code is freely available online at (https://github.com/AJFOWLER/covid_surgical_modelling).

Preregistration

A statistical analysis plan was published on our website prior to starting the analysis (doi: 10.17636/64678).